Elsevier,

The Journal of Climate Change and Health, Volume 4, 2021,100049

Given their carbon emissions, pharmaceutical companies must intensify their efforts and play an active role in addressing climate change.
Heightened emphasis on transparency and accountability through corporate governance and disclosure has renewed the focus on the ‘triple bottom line’—environmental, social and economic impacts. Environmental, social and corporate governance (ESG) reporting generally measures the sustainability and ethical performance of a company. There is increasing interest in the ESG performance of companies by various stakeholders. A range of mechanisms exist to shape CSR and foment voluntary reporting by companies on their ESG performance. Adhering to one such framework heightens credibility, and a proactive approach to sustainability presents opportunities while ensuring a company’s preparedness to embrace evolving legal requirements.
Educating the leaders of tomorrow is an essential part of a sustainable future.
Elsevier,

The Journal of Climate Change and Health, Volume 4, 2021,100043

An assessment of personal heat exposure measures and strategies to reduce heat risk.
Heating and cooling in buildings account for nearly 20% of energy use globally.
Many inhabited Greek/Mediterranean islands are unsustainable without mainland support due to lack of access to clean water and energy. This case study establishes the feasibility of sustainable green energy solutions for these settlements.
Elsevier, The Lancet Regional Health - Europe, Volume 7, August 2021
Change the paradigm in medical education: "the climate change generation"

Pages